SG70884G - Propanolamine derivatives - Google Patents

Propanolamine derivatives

Info

Publication number
SG70884G
SG70884G SG708/84A SG70884A SG70884G SG 70884 G SG70884 G SG 70884G SG 708/84 A SG708/84 A SG 708/84A SG 70884 A SG70884 A SG 70884A SG 70884 G SG70884 G SG 70884G
Authority
SG
Singapore
Prior art keywords
propanolamine derivatives
propanolamine
derivatives
Prior art date
Application number
SG708/84A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SG70884G publication Critical patent/SG70884G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
SG708/84A 1976-10-05 1984-10-05 Propanolamine derivatives SG70884G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762644833 DE2644833A1 (de) 1976-10-05 1976-10-05 Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SG70884G true SG70884G (en) 1985-04-04

Family

ID=5989679

Family Applications (1)

Application Number Title Priority Date Filing Date
SG708/84A SG70884G (en) 1976-10-05 1984-10-05 Propanolamine derivatives

Country Status (33)

Country Link
US (7) US4212877A (xx)
JP (1) JPS5368775A (xx)
AT (15) AT361908B (xx)
AU (1) AU514600B2 (xx)
BE (1) BE859415A (xx)
BG (1) BG33153A3 (xx)
CA (4) CA1101859A (xx)
CS (1) CS197304B2 (xx)
DD (5) DD148051A5 (xx)
DE (1) DE2644833A1 (xx)
DK (1) DK439077A (xx)
ES (16) ES462868A1 (xx)
FI (1) FI69066C (xx)
FR (1) FR2394534A1 (xx)
GB (3) GB1592976A (xx)
GR (1) GR64229B (xx)
HK (1) HK19385A (xx)
HU (1) HU177173B (xx)
IE (3) IE46158B1 (xx)
IL (1) IL53043A (xx)
LU (1) LU78240A1 (xx)
MY (1) MY8500909A (xx)
NL (1) NL7710840A (xx)
NO (1) NO151411C (xx)
NZ (1) NZ185356A (xx)
PH (4) PH15763A (xx)
PL (1) PL113879B1 (xx)
PT (1) PT67107B (xx)
SE (1) SE442400B (xx)
SG (1) SG70884G (xx)
SU (1) SU665801A3 (xx)
YU (1) YU40484B (xx)
ZA (1) ZA775905B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404380A (en) * 1977-02-14 1983-09-13 Mead Johnson & Company Triazolopyrimidines
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
BE883068A (fr) * 1979-05-04 1980-08-18 Continental Pharma Derives de benzimidazole, leur preparation, et utilisation ainsi que compositions contenant ces derives
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4473501A (en) * 1981-05-04 1984-09-25 G. D. Searle & Co. Dihydro azino isoquinolines
US4379508A (en) * 1981-10-14 1983-04-12 Nestier Corporation Nesting tray with stacking keyed interlock
IT1193608B (it) * 1983-01-21 1988-07-21 Pierrel Spa Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
DE3324903A1 (de) * 1983-07-09 1985-01-17 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe
GB8419797D0 (en) * 1984-08-03 1984-09-05 Beecham Group Plc Compounds
DE3807922A1 (de) * 1988-03-10 1989-09-21 Boehringer Mannheim Gmbh Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
TW203049B (xx) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US6557907B2 (en) 1993-05-14 2003-05-06 William W. Rowley Polyethylene connectors
US6860524B1 (en) 1993-05-14 2005-03-01 William W. Rowley Polyolefin connectors
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6848719B2 (en) 2001-09-06 2005-02-01 William W. Rowley Bendable polymer-lined water heater connector
TWI316511B (en) * 2002-11-26 2009-11-01 Smithkline Beecham Corp Calcilytic compounds
US20070117978A1 (en) * 2002-12-23 2007-05-24 Artesian Therapecutics, Inc Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2009070736A1 (en) * 2007-11-29 2009-06-04 Inolex Investment Corporation Preservatives for cosmetic, toiletry and pharmaceutical compositions
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284529A (xx) * 1961-10-24
GB1066613A (en) * 1965-03-03 1967-04-26 Ici Ltd Naphthalene derivatives
NL145842B (nl) * 1969-11-28 1975-05-15 Teikoku Hormone Mfg Co Ltd Werkwijze voor het bereiden van 1-aryloxy 3-amino 2-propanolderivaten.
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US3818017A (en) * 1973-01-04 1974-06-18 Janssen Pharmaceutica Nv 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3894030A (en) * 1973-01-04 1975-07-08 Janssen Pharmaceutica Nv 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
GB1456525A (en) * 1973-07-18 1976-11-24 Ici Ltd Process for the manufacture of alkanolamine derivatives
DE2503222A1 (de) * 1975-01-27 1976-07-29 Boehringer Sohn Ingelheim Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (xx) * 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
IE46158B1 (en) 1983-03-09
NO151411C (no) 1985-04-10
ZA775905B (en) 1979-06-27
IE822410L (en) 1978-04-05
PH19028A (en) 1985-12-06
US4296117A (en) 1981-10-20
JPS6210988B2 (xx) 1987-03-10
YU40484B (en) 1986-02-28
CS197304B2 (en) 1980-04-30
GB1592975A (en) 1981-07-15
ATA57180A (de) 1980-09-15
PT67107A (de) 1977-11-01
NO151411B (no) 1984-12-27
NO773384L (no) 1978-04-06
BE859415A (fr) 1978-04-05
AT363079B (de) 1981-07-10
CA1126271A (en) 1982-06-22
IL53043A0 (en) 1977-12-30
ATA56980A (de) 1980-09-15
AT361908B (de) 1981-04-10
DD148051A5 (de) 1981-05-06
ES471799A1 (es) 1979-02-01
ATA57580A (de) 1980-12-15
IE46159B1 (en) 1983-03-09
MY8500909A (en) 1985-12-31
ES471807A1 (es) 1979-02-01
HK19385A (en) 1985-03-22
ES471808A1 (es) 1979-02-01
ATA57880A (de) 1980-10-15
FR2394534A1 (fr) 1979-01-12
ATA679377A (de) 1980-09-15
DK439077A (da) 1978-04-06
ES471803A1 (es) 1979-02-01
SE7711168L (sv) 1978-05-18
FI69066C (fi) 1985-12-10
US4255430A (en) 1981-03-10
PT67107B (de) 1980-04-07
PH15763A (en) 1983-03-22
CA1125751A (en) 1982-06-15
DD148052A5 (de) 1981-05-06
GR64229B (en) 1980-02-14
FI772823A (fi) 1978-04-06
PL113879B1 (en) 1981-01-31
LU78240A1 (xx) 1979-02-02
ES471805A1 (es) 1979-02-01
IL53043A (en) 1982-01-31
DD148050A5 (de) 1981-05-06
FI69066B (fi) 1985-08-30
US4381309A (en) 1983-04-26
AT362362B (de) 1981-05-11
PH18363A (en) 1985-06-13
IE46158L (en) 1978-04-05
ES471802A1 (es) 1979-02-01
DD134642A5 (de) 1979-03-14
AT362363B (de) 1981-05-11
CA1101859A (en) 1981-05-26
BG33153A3 (en) 1982-12-15
NZ185356A (en) 1981-05-01
ES471798A1 (es) 1979-02-01
ES471795A1 (es) 1979-02-01
ATA57080A (de) 1980-09-15
ATA58080A (de) 1981-04-15
ES462868A1 (es) 1978-12-16
AU514600B2 (en) 1981-02-19
AT364828B (de) 1981-11-25
GB1592977A (en) 1981-07-15
YU236977A (en) 1983-01-21
AT363082B (de) 1981-07-10
ES471797A1 (es) 1979-02-01
ES471796A1 (es) 1979-02-01
PH16053A (en) 1983-06-09
IE46160B1 (en) 1983-03-09
AT363080B (de) 1981-07-10
AT362364B (de) 1981-05-11
CA1127643A (en) 1982-07-13
NL7710840A (nl) 1978-04-07
US4343800A (en) 1982-08-10
DD143074A5 (de) 1980-07-30
ATA57680A (de) 1980-12-15
ATA57380A (de) 1980-10-15
JPS5368775A (en) 1978-06-19
US4212877A (en) 1980-07-15
ATA57280A (de) 1980-10-15
ATA56880A (de) 1980-09-15
AT361914B (de) 1981-04-10
AT361913B (de) 1981-04-10
US4604468A (en) 1986-08-05
ES471801A1 (es) 1979-02-01
ATA57980A (de) 1980-12-15
AT361912B (de) 1981-04-10
DE2644833A1 (de) 1978-04-20
GB1592976A (en) 1981-07-15
PL201286A1 (pl) 1978-12-04
HU177173B (en) 1981-08-28
IE822409L (en) 1978-04-05
SE442400B (sv) 1985-12-23
SU665801A3 (ru) 1979-05-30
AT361915B (de) 1981-04-10
ES471804A1 (es) 1979-02-01
FR2394534B1 (xx) 1982-04-30
ATA56780A (de) 1980-09-15
AU2933377A (en) 1979-04-12
ES471800A1 (es) 1979-02-01
AT361911B (de) 1981-04-10
US4256756A (en) 1981-03-17
AT363081B (de) 1981-07-10
AT362365B (de) 1981-05-11
ATA57480A (de) 1980-10-15
ES471806A1 (es) 1979-02-01
ATA57780A (de) 1980-12-15
ES471794A1 (es) 1979-02-01

Similar Documents

Publication Publication Date Title
MY8500909A (en) Propanolamine derivatives
PH14332A (en) 4-hydroxyphenylalkanolamine derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
GB1554517A (en) Nogarol derivatives
PT66360A (en) Nicotinoylaminotriazine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
GB1549755A (en) N-4-halobutyryl derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
ZA773485B (en) Hydrazinopyridazine derivatives
JPS532487A (en) Quinoxalinee1*44dioxide derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
JPS52100431A (en) Anilinoacetate derivatives
JPS5297915A (en) Alkylaminoglucopyranoside derivatives
JPS5283495A (en) Thienothiazine derivatives
PH13411A (en) 8-adnantylaninometryl ergolene derivatives
GB1544289A (en) Thiazolinotriazine derivatives
AU2536577A (en) 2-nitroindandione derivatives
AU2680877A (en) Arylaminopyrimidine derivatives
GB1535080A (en) Naphthacenequinone derivatives
JPS5283696A (en) Cephalospoline derivatives